Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 179-181

  Costa, Francesco ^a   Adamo, Marianna ^a,b   Ariotti, Sara ^a   Navarese, Eliano Pio ^c   Biondi Zoccai, Giuseppe ^d   Valgimigli, Marco ^a,b,c,d,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BRESCIA   (Italy)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Clopidogrel; DAPT; Prasugrel; Thienopyridines; Ticagrelor

Indexed keywords

CLOPIDOGREL; PLACEBO; PRASUGREL; TICAGRELOR; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; FATALITY; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; CLASSIFICATION; CLINICAL TRIAL (TOPIC); COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; META ANALYSIS; MORTALITY; PROCEDURES; TIME FACTOR; TRENDS;

ASPIRIN; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; MORTALITY; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TICLOPIDINE; TIME FACTORS;

EID: 84943530625     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.08.058     Document Type: Article

References (10)

1. L. Mauri, D.J. Kereiakes, R.W. Yeh, P. Driscoll-Shempp, D.E. Cutlip, P.G. Steg, and et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N. Engl. J. Med. 371 2014 2155 2166
2. M.P. Bonaca, D.L. Bhatt, M. Cohen, P.G. Steg, R.F. Storey, E.C. Jensen, and et al. Long-term use of ticagrelor in patients with prior myocardial infarction N. Engl. J. Med. 372 2015 1791 1800
3. E.P. Navarese, F. Andreotti, V. Schulze, M. Kolodziejczak, A. Buffon, M. Brouwer, and et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials BMJ 350 2015 h1618
4. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
5. J.P. Collet, J. Silvain, O. Barthelemy, G. Range, G. Cayla, E. Van Belle, and et al. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial Lancet 384 2014 1577 1585
6. C.W. Lee, J.M. Ahn, D.W. Park, S.J. Kang, S.W. Lee, Y.H. Kim, and et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial Circulation 129 2014 304 312
7. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N. Engl. J. Med. 361 2009 1045 1057
8. F. Costa, P. Vranckx, S. Leonardi, E. Moscarella, G. Ando, P. Calabro, and et al. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial Eur. Heart J. 36 2015 1242 1251
9. R.W. Yeh, D.J. Kereiakes, P.G. Steg, S. Windecker, M.J. Rinaldi, A.H. Gershlick, and et al. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction J. Am. Coll. Cardiol. 65 2015 2211 2221
10. K.N. Garratt, W.D. Weaver, R.G. Jenkins, T.K. Pow, L. Mauri, D.J. Kereiakes, and et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberte paclitaxel-eluting coronary stent placement Circulation 131 2015 62 73